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Glutamate is the major excitatory neurotransmitter in brain exerting prosurvival effect on neurons via N-methyl-D-aspartate 
receptor (NMDAR) signaling under physiological conditions. However in pathological circumstances such as ischemia, NMDARs 
might have proapoptotic excitotoxic activity. In contrast brain-derived neurotrophic factor (BDNF) signaling via tropomyosin-
related receptor kinase B (TrkB) has been largely considered to promote neuronal differentiation, plasticity and survival during 
normal development, and protect neurons in pathophysiological conditions antagonizing the NMDAR-mediated excitotoxic cell 
death. In this review we summarize recent evidence for the existent crosstalk and positive feedback loops between the BDNF and 
NMDAR signaling and point out some of the important specific features of each signaling pathway. 
Biomed Rev 2008; 19: 17-27.
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INTRODUCTION
Neurotransmitters and growth factors promote growth, 
survival and differentiation of neurons in central nervous 
system. Moreover, in adult brain they participate in synaptic 
signaling and synaptic remodeling, which underlie learning 
and memory formation (1). While N-methyl-D-aspartate 
receptor (NMDAR) signaling is physiologically essential for 
neuronal survival (2), it might have excitotoxic proapoptotic 
effect under pathophysiological conditions such as ischemia 
(3-5). In contrast brain-derived neurotrophic factor (BDNF) is 
considered to have predominantly prosurvival activity both in 
health and disease and its tropomyosin-related receptor kinase 
B or tyrosine receptor kinase B (TrkB) signaling is a major 
protective mechanism against ischemic injury (6). In this 
review we focus on the recent progress made in elucidating 
the mechanisms for crosstalk between BDNF and NMDAR 
prosurvival signaling pathways.
CALCIUM AS A SECOND MESSENGER
NMDAR-mediated Ca2+ increase
Glutamate-mediated trophic effects in the brain depend on 
the type of receptors, intensity of the signal, and the signaling 
context (7-10). Undoubtedly one of the most intricate signaling 
pathways involves the NMDARs, which are excitatory hetero-
tetramer channels highly permeable for Ca2+ ions, require 
the coagonist glycine for proper function and are subject to 
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voltage-dependent block by physiological Mg2+ concentra-
tions. Blockade of normal NMDAR function induces apoptotic 
cell death of cortical and thalamic neurons (11-13). Currently 
there are seven NMDAR subunits known: NR1 (ζ1), NR2A-D 
(ε1-4) and NR3A-B (14,15). For five of the subunits (NR1, 
NR2B, NR2C, NR2D and NR3A) are reported splice variants. 
Most native NMDARs are assembled of two glycine-binding 
NR1 and two glutamate-binding NR2 subunits. NMDARs are 
therefore NR2-containing receptors in which NR1/NR2 het-
erodimers (Fig. 1) appear to be the functional unit (16). NR3 
subunit containing NMDARs are expressed at late postnatal 
stages of CNS neuronal development (17) and could be either 
NR1/NR2/NR3 heteromeric channels with decreased Ca2+ 
permeability (18), or excitatory NR1/NR3 glycine receptors, 
which are insensitive for glutamate or NMDA (19). Activation 
of NMDARs leads to direct Ca2+ influx, and subsequent activa-
tion of Ca2+-dependent protein kinases or protein phosphatases, 
which act as intracellular messengers.
Figure 1. NMDAR signaling - triggering of Ca2+/CaMK, PI3K/Akt and Ras/MEK/ERK pathways. Abbreviations: ERK, extra-
cellular signal-regulated kinase; NMDAR, N-methyl-D-aspartate receptor;  pCREB, phosphorylated cAMP response element-
binding protein; PDK-1, phosphoinositide-dependent kinase-1; PI3K, phosphatidylinositol-3 kinase; PIP2, phosphatidylinositol 
4,5 bisphosphate; PIP3, phosphatidylinositol-3,4,5-trisphosphate.
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TrkB-mediated Ca2+ increase
BDNF exerts its effect through TrkB that has tyrosine kinase 
activity triggering several distinct biochemical pathways, 
amongst which is the activation of γ-isoform of phospholipase 
C (PLC-γ). PLC-γ further cleaves phosphatidylinositol-4,5-
bisphosphate (PIP2) to produce diacylglycerol (DAG) and 
inositol-1,4,5-trisphosphate (IP3), the latter binding to IP3 re-
ceptors (IP3Rs) releasing Ca2+ from the endoplasmic reticulum. 
However, TrkB receptor activation also potentiates the Ca2+ 
influx through NMDARs via NR1 subunit phosphorylation 
(20) or NR2B subunit phosphorylation (21). It has been also 
shown that TrkB, Fyn and NR2B subunit form a multimeric 
protein complex and the extent of TrkB-Fyn-NR2B protein in-
teraction increases in behavioral tests for spatial learning (22).
THE CALMODULIN/CAMK PATHWAY
NMDAR-mediated calmodulin/CaMK activation
Glutamate binding to NMDARs in the presence of the coag-
onist glycine directly opens the ion channel pore leading to 
Ca2+ influx from the extracellular space. Ca2+ ions then activate 
calmodulin, which is a small, acidic protein with a molecular 
mass ~17 kDa. It contains four EF-hand motifs, each of which 
binds a Ca2+ ion. Ca2+/calmodulin complex further activates 
Ca2+/calmodulin-dependent protein kinase kinase (CaMKK), 
which phosphorylates Ca2+/calmodulin-dependent protein 
kinases I and IV (CaMKI/IV), but not CaMKII, which is regu-
lated by autophosphorylation. Though it did not seem clear 
why both the enzyme (CaMKK) and its substrates (CaMKs) 
both require binding of Ca2+/calmodulin (23),  now there is an 
evidence that CaMKK phosphorylates and activates protein 
kinase B (PKB) triggering an alternative cascade pathway, and 
by this, has an anti-apoptotic effect on the cell (24). CaMK 
has several isoforms, of which CaMKIV is predominantly 
nuclear, while CaMKII may exist in the cytoplasm or nucleus, 
depending on the isoform mix of the heteromultimerized 
holoenzyme (25). In postsynaptic space CaMKII mediates 
long-term potentiation (LTP), which underlies memory stor-
age and formation. Interestingly, CaMKII activity is regulated 
via docking to NR1 and NR2B subunits of NMDARs, where 
it might be locked in an active conformation (26,27). Auto-
phosphorylated CaMKIIα binds directly to NMDARs in the 
postsynaptic density, and phosphorylates NR2B subunits at 
S1303, which leads to NR2B NMDAR desensitization (28). In 
cultured rat cerebellar granule neurons the pharmacological 
intervention either with CaMKII/IV inhibitor KN62 (29) or 
calmodulin inhibitor W13 (30) blocked the protective effects 
of NMDA against exposure to low level K+ medium. Both 
CaMKII and CaMKIV might phosphorylate CREB at S133 thus 
enhancing target gene expression such as BDNF (31). Moreo-
ver, it has been suggested that BDNF expression via pCREB is 
due to synaptic NMDAR activation, and not to extrasynaptic 
NMDAR function (32). Although initially it has been proposed 
that extrasynaptic NMDARs are NR2B, while synaptic are 
NR2A, and this subunit composition difference might explain 
the different roles of synaptic and extrasynaptic NMDARs in 
cell survival (32,33), currently there is evidence that NR2B 
receptors in synapses have prosurvival function, while NR2B 
receptors in extrasynaptic locations mediate cell death. This 
has been shown in rat primary hippocampal neuronal cultures, 
at an early developmental stage where the immature neurons 
express NR2B NMDARs both in synaptic and extrasynaptic 
locations, but do not express NR2A (8). Interestingly, it was 
shown that 65% of synaptic NMDARs are exchanged with ex-
trasynaptic ones in less than 7 min via lateral diffusion process 
(34,35), which implies that the supramolecular organization 
and recruitment of specific transduction pathways to synaptic 
NMDARs is critical for NMDA-mediated survival.
TrkB-mediated calmodulin/CaMK activation
BDNF is a peptide with a molecular mass ~13kDa, which 
forms stable homodimers that are secreted in both constitutive 
and regulated pathways. Binding of BDNF homodimers to 
TrkB receptors triggers ligand-induced receptor dimerization 
and autophosphorylation of tyrosine residues in the intracel-
lular kinase domain (Fig.2), and at the Y515-Shc and Y816-PLCγ 
sites (36). Activation of PLCγ leads to IP3-dependent release 
of Ca2+ from the internal stores with subsequent calmodulin 
and CaMKII or CaMKIV activation.
THE PI3K/AKT PATHWAY
NMDAR-mediated PI3K/Akt activation
Ca2+ influx through the NMDAR receptor leads to activation 
of the GTP/GDP exchange factor RasGRF via calmodu-
lin (37), with subsequent activation of Ras having diverse 
intracellular effects amongst which is activation of PI3K 
(38,39). Phosphatidylinositol-3 kinase (PI3K)  phosphorylates 
phosphatidylinositols  of  the  cell  membrane,  thus  generat-
ing phosphatidylinositol-3,4,5-trisphosphate  (PIP3)  from 
phosphatidylinositol-4,5-bisphosphate (PIP2). PIP3 at the cell 
membrane recruits protein kinases such as PKB (known also as 
Akt kinase) and phosphoinositide-dependent kinase-1 (PDK-
1), which bind with their pleckstrin homology (PH) domain to 
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PIP3 (40). Activation of PKB/Akt requires the phosphorylation 
by PDK-1, which is regulated by the conformation of PKB/
Akt. Specifically, the engagement of the PH domain on the 
membrane by binding PIP3 relieves autoinhibition of the active 
site, allowing PDK-1 to access T308 on the PKB/Akt activa-
tion loop (41). Though PDK-1 is a major activator of PKB/
Akt, there is a crosstalk with the calmodulin/CaMK pathway 
since both CaMK and CaMKK phosphorylate PKB/Akt (42). 
Active PKB then promotes growth and protein translation 
via phosphorylation of mTOR (43), and it was shown that 
NMDAR mediated neuroprotection requires both transcription 
activation and synthesis of new proteins (44). Moreover, PKB/
Akt suppresses apoptosis via triggering phosphorylation of 
Bad, caspase 9, GSK-3β (45) or dephosphorylation of MKL3, 
JNK and c-Jun (46). The importance of PI3K/Akt signaling in 
NMDAR pro-survival activity has been shown in cultured rat 
cerebellar granule neurons, where PI3K inhibition with either 
LY294002 (47) or wortmanin (48) reduced NMDA protection 
against apoptosis in low level K+ medium (49).
TrkB-mediated PI3K/Akt activation
BDNF activation of TrkB, leads to phosphorylation of the 
Y515-Shc receptor site that recruits Shc protein and subsequent 
activation of Grb2, Gab-1 and PI3K (50). PI3K then might 
mediate activation of PKB/Akt, which activates the kinase 
mTOR (Fig. 3). mTOR further phosphorylates eIF4E-binding 
proteins (4E-BPs), which leads to eukaryotic initiation factor 
4E (eIF4E) liberation and local spine translation of CaMKII, 
Figure 2. BDNF/TrkB signaling - triggering of Ca2+/CaMK, PI3K/Akt and Ras/MEK/ERK pathways. Abbreviations: BDNF, 
brain-derived neurotrophic factor; DAG, diacylglycerol; Grb2, growth factor receptor bound protein-2; IP3, inositol-1,4,5-
trisphosphate; PLC, phospholipase C.
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Arc (activity-regulated cytoskeletal-associated protein), 
LIMK1 and GluR1, mediating the BDNF trophic effect on 
dendritic spines (51). Additional bifurcation of the biochemical 
pathway occurs at Grb2, which might activate SOS, followed 
by Ras, Raf, MEK, and ERK-1/2 activation (50). Mutations 
in TrkB Y515-Shc receptor site impair both PI3K and MEK 
signaling pathways, thereby compromising neuronal survival 
and local axon growth (52).
THE ERK-1/2 PATHWAY
NMDAR-mediated ERK activation
NMDAR activation activates Ras via Ca2+/calmodulin-depend-
ent activation of Ras-GRF (39) or enhancement of nitric oxide 
(NO) production by neuronal NO synthase (nNOS), which 
is anchored to NMDARs via PSD-95 (53). Ras has a critical 
cysteine group which is nitrosylated and thus mediates the NO 
mediated activation (54). Except for activation of PI3K, Ras 
further activates Raf (also known as mitogen-activated protein 
kinase kinase kinase, MAPKKK), MEK-1/2 (also known as 
mitogen-activated protein kinase kinase, MAPKK), and ERK-
1/2 (also known as mitogen-activated protein kinase, MAPK) 
(55). Recent evidence shows however that NMDAR-mediated 
ERK activation requires a specific coupling of NMDAR, Src 
and ERK, via caveolin-1, which helps the assembly of the 
signaling cascade within the neuronal lipid rafts (56). The 
organization of supramolecular complexes for NMDAR/
ERK signal transduction explains the interesting observation 
that synaptic NMDARs activate ERK, while extrasynaptic 
Figure 3. Akt/ERK control of protein translation and cellular activities (cytoskeletal dynamics, releasable pool of synaptic 
vesicles, apoptosis, etc.). Abbreviations: 4E-BPs, eIF4E-binding proteins; eIF4E, eukaryotic initiation factor 4E; FAK, focal 
adhesion kinase; MAPs, microtubule-associated proteins; MLCK, myosin light polypeptide kinase; mRNA, messenger RNA; 
tRNA, transport RNA.
22
Biomed Rev 19, 2008
Georgiev, Taniura, Kambe, and Yoneda
NMDARs trigger ERK shut off pathway (57,58). Activation of 
ERK-1/2 leads to CREB phosphorylation, expression of pro-
survival/anti-apoptotic target genes (59) and activation of DNA 
repair enzymes (60). Other important intraneuronal targets 
phosphorylated by ERK-1/2 are the microtubule-associated 
proteins (MAPs), which participate in building the neuronal 
microtubule cytoskeleton (61). ERK-1/2 also phosphorylates 
myosin light polypeptide kinase (MLCK), calpain, paxillin-6 
and focal adhesion kinase (FAK) that play important role in 
cytoskeletal rearrangement. Protein synthesis is controlled by 
ERK-1/2 via direct phosphorylation of 40S ribosomal protein 
S6 kinase (S6K), which further phosphorylates the ribosomal 
protein S6 and stimulates the cap-dependent translation (62). 
Moreover, ERK-1/2 enhances the release of neurotransmitters 
via phosphorylation of synapsin-1, which docks the synaptic 
vesicles in the presynaptic space (63). ERK-1/2 also mediates 
anti-apoptotic effects via phosphorylation of Bad (64), caspase 
9 (65), and GSK-3β (42).
TrkB-mediated ERK activation
BDNF activation of TrkB receptor also triggers ERK-1/2 
pathway, via Ras, Raf and MEK. ERK-1/2 activity further 
mediates Arc gene expression and Arc mRNA transport to 
dendritic spines. Local Arc protein synthesis leads to formation 
of Arc/cofilin complexes, which reduce cofilin activity and 
thus promote actin polymerization and growth of dendritic 
spines (66). Cofilin phosphorylation at S3 also inhibits cofilin 
activity and enhances actin polymerization. The growth of 
the F-actin cytoskeleton transforms the active spines into big 
mushroom spines, which underlies the formation of long-term 
synaptic memory. In addition to the BDNF triggered PKB/
Akt activation of mTOR, which regulates the availability of 
eIF4E, ERK-1/2 activates Mnk1 kinase, which phosphorylates 
eIF4E at S209 (51). The latter phosphorylation is considered to 
be a rate limiting step in protein translation. Therefore BDNF 
controls both the availability and activity of translation factors 
via bifurcation of the biochemical cascades at Grb2 or Ras.
BDNF-NMDAR POSITIVE FEEDBACK LOOPS
NMDAR mediated prosurvival activity in many cases is 
believed to be result from autocrine BDNF secretion and 
subsequent activation of ERK-1/2 and PKB/Akt pathways 
(67). NMDAR activation at postsynaptic sites leads to activ-
ity dependent BDNF release from secretory granules in the 
postsynaptic neurons, mediating retrograde BDNF signaling 
in the synapse (68). However, electric activity also stimulates 
BDNF transport along the axon, and subsequent release from 
the presynaptic terminals of cortical neurons (69). Both cited 
studies used overexpression of BDNF-GFP fusion protein 
and both studies reported co-existent axonal and dendritic 
localization of the BDNF secretory granules, therefore it is 
essential to assume that BDNF acts both as anterograde and 
retrograde synaptic messenger. Secreted BDNF acts both 
on presynaptic and postsynaptic TrkB receptors, either to 
facilitate neuromediator release presynaptically (63) or to 
contribute to postsynaptic LTP mediated by enhancement of 
NMDAR and L-type VGCC function (70). It is interesting to 
note however that NMDAR function does not only regulate 
the autocrine secretion of BDNF, it has been shown that 
basal level of intracellular Ca2+ gates the TrkB receptor func-
tion and the subsequent activation of the PI3K/Akt pathway 
via calmodulin (71). Conversely, BDNF rapidly augments 
glutamatergic synaptic transmission via enhanced activity 
of NR2B NMDARs (72). BDNF-activated TrkB receptors 
form macromolecular complexes with Fyn kinase and NR2B 
NMDARs, leading to NR2B phosphorylation and potentiation 
of the NR1/NR2B NMDAR-mediated Ca2+ influx. Fyn kinase 
attaches with its SH2 domain to the C-terminal tail of NR2B 
NMDARs and phosphorylates tyrosine residues at three dif-
ferent sites - Y1252, Y1336 and Y1472 (21,73,74). Additionally, 
BDNF enhances NMDAR ionic currents by stabilization of 
microtubules and promotion of microtubule-dependent trans-
port of NR2B subunits with their subsequent incorporation in 
the dendritic membrane (75). This completes a fast positive 
feedback loop between NMDAR and BDNF signaling (Fig.4) 
– NMDAR function leads to activity-dependent BDNF release 
from secretory granules and Ca2+-dependent gating of TrkB 
function, while BDNF-mediated TrkB activation potentiates 
NMDAR currents and controls the NMDAR insertion in the 
dendritic membrane.
There is a second much slower positive feedback loop 
at the level of gene transcription. Particularly it has been 
shown that synaptic NMDAR activity leads to enhanced 
CREB phosphorylation and BDNF gene expression (32,76). 
NMDAR-mediated Ca2+ entry leads to decreased BDNF gene 
methylation (77) and upregulation of BDNF promoter III, via 
binding of pCREB, USF, and the novel Ca2+-responsive tran-
scription factor CaRF (78,79) and derepresses the BDNF pro-
moter IV activity, which is negatively regulated by BHLHB2 
(80). NMDAR-activity regulated gene expression depends 
also on the NR1 subunit splice variants, and particularly on 
the inclusion of exon 21 encoding for the C1 cassette (81). 
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Figure 4. NMDAR-BDNF fast positive feedback loop. NMDAR activation leads to BDNF secretion from postsynaptic neurons, 
while BDNF enhances postsynaptic NMDAR currents via TrkB/Fyn/NR2B phosphorylation.
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Moreover, it has been shown that NMDAR activity leads to 
transport and accumulation of  mRNABNDF in distal dendrites, 
which accounts for local BDNF translation (82). Conversely, 
BDNF seems to be essential for NR2A but not NR2B subunit 
expression in cortex (83,84), and interestingly in cerebellum 
BDNF promotes the replacement of NR2B with NR2C subu-
nits during neuronal maturation (85).
CONCLUDING REMARKS 
The existence of fast and slow positive feedback loops as well 
as existence of multiple crosstalk possibilities at all major 
biochemical pathways triggered by NMDA or BDNF makes 
it extremely difficult to delineate the relative contributions 
of classical neurotransmitters (glutamate) and neurotrophins 
(BDNF) in prosurvival signaling. Recent data suggests that 
neurotransmitters such as glutamate might have ‘trophic’ ef-
fects in central nervous system, while neurotrophins might 
act as ‘neurotransmitters’ having fast modulating effects on 
synaptic function. Thus neurotransmitters and neurotrophins 
operate in concert and have overlapping functions in vivo, 
and the smearing of boundaries between these two groups of 
signaling molecules reflects the rapid progress in neurosciences 
made in the past decade.
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